Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/publikationen/10877-survival-analysis-of-the-randomised-phase-iii-geparocto-trial-comparing-neoadjuvant-chemotherapy-of-intense-dose-dense-epirubicin-paclitaxel-cyclophosphamide-versus-weekly-paclitaxel-liposomal-doxorubicin-plus-carboplatin-in-triple-negative-breast-cancer-for-patients-with-high-risk-early-breast-cancer/autoren